| abstract |
The aim of the invention is to expand the range of benzimidazolone derivatives, which are, in particular, an antagonist of the 5-HT1A and 5-HT2 receptor. This goal is achieved by the proposed benzimidazolone derivatives of general formula (I) (I) where R1 and R2 are the same or different and mean a hydrogen atom, a halogen atom, alkyl with 1-6 carbon atoms, alkoxy with 1-6 carbon atoms, R3 is an atom hydrogen, alkyl with 1-6 carbon atoms, alkenyl with 2-6 carbon atoms, A is the -CO- or -CONH- group, or A is absent, B is an unbranched saturated alkyl with 2-6 carbon atoms, R4 is phenyl, naphthyl, unsubstituted or substituted by at least one substituent from the group consisting of a fluorine or chlorine atom, trifluoromethyl, methoxy, ethoxy, methyl, ethyl, or benzodioxane, m and n each means the number 2, and their physiologically tolerable acid addition salts. |